Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
RM Pallares, RJ Abergel - Frontiers in medicine, 2022 - frontiersin.org
Targeted alpha therapy is an oncological treatment, where cytotoxic doses of alpha radiation
are locally delivered to tumor cells, while the surrounding healthy tissue is minimally …
are locally delivered to tumor cells, while the surrounding healthy tissue is minimally …
Understanding the biological behavior of lanthanides and actinides through omics approaches
RM Pallares, Y Li, RJ Abergel - TrAC Trends in Analytical Chemistry, 2023 - Elsevier
Lanthanides and actinides are a series of critical elements commonly used in multiple
industries, such as energy production, optoelectronics, and healthcare. Despite their …
industries, such as energy production, optoelectronics, and healthcare. Despite their …
A review of recent advancements in Actinium‐225 labeled compounds and biomolecules for therapeutic purposes
M Hassan, TH Bokhari, NA Lodhi… - Chemical Biology & …, 2023 - Wiley Online Library
In nuclear medicine, cancers that cannot be cured or can only be treated partially by
traditional techniques like surgery or chemotherapy are killed by ionizing radiation as a form …
traditional techniques like surgery or chemotherapy are killed by ionizing radiation as a form …
短飛程放射線を利用した核医学治療薬剤の開発状況
公社 - RADIOISOTOPES, 2024 - jstage.jst.go.jp
抄録 日本アイソトープ協会理工・ライフサイエンス部会放射線照射標的分子探索専門委員会は,
短飛程放射線の物理化学的な性質と細胞レベルでの生物学的効果や殺細胞の分子メカニズム …
短飛程放射線の物理化学的な性質と細胞レベルでの生物学的効果や殺細胞の分子メカニズム …
ラジオセラノスティクス(核医学検査から核医学治療まで) に関連する職業被ばく
伊藤公輝, 冨永沙耶香 - RADIOISOTOPES, 2024 - jstage.jst.go.jp
抄録 近年注目されているラジオセラノスティクスでは, 患者の体内に投与された放射性同位元素
から放出される放射線により, わずかではあるものの医療従事者への被ばくが生じる …
から放出される放射線により, わずかではあるものの医療従事者への被ばくが生じる …